AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 45 filers reported holding AEVI GENOMIC MEDICINE INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $24,000 | +1100.0% | 160,264 | +994.7% | 0.00% | – |
| Q2 2019 | $2,000 | -84.6% | 14,640 | -77.9% | 0.00% | – |
| Q1 2019 | $13,000 | +18.2% | 66,311 | +320.4% | 0.00% | – |
| Q4 2018 | $11,000 | -76.6% | 15,774 | -58.3% | 0.00% | – |
| Q3 2018 | $47,000 | +95.8% | 37,796 | +214.4% | 0.00% | – |
| Q1 2018 | $24,000 | -29.4% | 12,021 | -57.2% | 0.00% | – |
| Q4 2017 | $34,000 | +54.5% | 28,090 | +62.0% | 0.00% | – |
| Q3 2017 | $22,000 | -82.0% | 17,338 | -73.6% | 0.00% | – |
| Q1 2017 | $122,000 | -57.3% | 65,576 | +18.6% | 0.00% | – |
| Q4 2016 | $286,000 | – | 55,281 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|